Table 3.

Average concentration mediators (pg/mL) in blood plasma after 24 h of pre-incubation with non-digestible oligosaccharides.

Mediator	Control ± SEM	scGOS/lcFOS ± SEM	scFOS/lcFOS ± SEM	Galectin-9 (1 µg/mL) ± SEM	Galectin-9 (5 µg/mL) ± SEM
IL-4	4 ± 0.8	3 ± 0.9	3 ± 0.7	3 ± 0.4	4 ± 0.6
IL-5a	13 ± 6	11 ± 5	9 ± 3	9 ± 2	11 ± 3
GM-CSFa	28 ± 5	23 ± 4	23 ± 3	20 ± 2	25 ± 3
MDC	444 ± 39	458 ± 36	454 ± 33	472 ± 44	507 ± 42
TARC	15 ± 2	15 ± 2	15 ± 2	15 ± 2	15 ± 2
Eotaxin-3	254 ± 48	245 ± 50	251 ± 51	256 ± 53	262 ± 52
RANTES	39,679 ± 4,131	40,454 ± 5,155	39,055 ± 4,537	37,172 ± 4,396	36,854 ± 4,178
Galectin-3	42,093 ± 3,210	35,832 ± 2,878	46,998 ± 9,034	45,240 ± 6,155	37,298 ± 2,584

^aValues out of range below.

scFOS/lcFOS, short- and long-chain fructo-oligosaccharides; scGOS, short-chain galacto-oligosaccharides.